New patent expiration for Celgene drug POMALYST

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for POMALYST
Annual Drug Patent Expirations for POMALYST

Pomalyst is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are eleven patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for POMALYST.

This drug has three hundred and thirty-nine patent family members in forty-seven countries.

The generic ingredient in POMALYST is pomalidomide. One supplier is listed for this compound. Additional details are available on the pomalidomide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top